Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C11H13NO4 |
Molecular Weight | 223.2252 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O
InChI
InChIKey=CAHKINHBCWCHCF-JTQLQIEISA-N
InChI=1S/C11H13NO4/c1-7(13)12-10(11(15)16)6-8-2-4-9(14)5-3-8/h2-5,10,14H,6H2,1H3,(H,12,13)(H,15,16)/t10-/m0/s1
Molecular Formula | C11H13NO4 |
Molecular Weight | 223.2252 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: http://www.jarrow.com/product/65/N-Acetyl_TyrosineCurator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/14621123 and https://yurielkaim.com/n-acetyl-l-tyrosine/
Sources: http://www.jarrow.com/product/65/N-Acetyl_Tyrosine
Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/14621123 and https://yurielkaim.com/n-acetyl-l-tyrosine/
N-Acetyltyrosine is an acetylated derivative of the amino acid L-tyrosine. Ordinary L-tyrosine is less stable and also less soluble in water, which may result in reduced bioavailability. Acetylation enhances the solubility and stability of certain amino acids. N-Acetyltyrosine is commonly used in place of tyrosine in parenteral nutrition. It converts to tyrosine and then can be used in neurotransmitter treatment as a precursor of cathecholamine. N-Acetyltyrosine supports brain function by supporting the synthesis of the catecholamines norepinephrine and dopamine (neurotransmitters). N-Acetyltyrosine supplements are used to improve memory and cognitive performance in humans while they are experiencing psychological stress.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Staphylococcus aureus toxic shock syndrome toxin 1 production Sources: http://www.ncbi.nlm.nih.gov/pubmed/19223628 |
|||
Target ID: Staphylococcus aureus growth Sources: http://www.ncbi.nlm.nih.gov/pubmed/19223628 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | TrophAmine Approved UseTrophAmine is indicated for the nutritional support of infants (including those of low birth weight) and young
pediatric patients requiring TPN via either central or peripheral infusion routes. Parenteral nutrition with
TrophAmine is indicated to prevent nitrogen and weight loss or treat negative nitrogen balance in infants and
young pediatric patients where (1) the alimentary tract, by the oral, gastrostomy, or jejunostomy route, cannot or
should not be used, or adequate protein intake is not feasible by these routes; (2) gastrointestinal absorption of
protein is impaired; or (3) protein requirements are substantially increased as with extensive burns. Launch Date1984 |
Sample Use Guides
In Vivo Use Guide
Curator's Comment: Can also be injected, if N-Acetyltyrosine is an ingredient of hypertonic solutions containing crystalline amino acids for nutritional support and therapy http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19018scs018_trophamine_lbl.pdf
The best dosage range of NALT (N-Acetyltyrosine) is between 200-500 mgs per day. This can be taken all at once or spread throughout your day.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:52:22 GMT 2023
by
admin
on
Fri Dec 15 15:52:22 GMT 2023
|
Record UNII |
DA8G610ZO5
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Official Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
3506 (Number of products:19)
Created by
admin on Fri Dec 15 15:52:23 GMT 2023 , Edited by admin on Fri Dec 15 15:52:23 GMT 2023
|
||
|
LOINC |
79514-6
Created by
admin on Fri Dec 15 15:52:23 GMT 2023 , Edited by admin on Fri Dec 15 15:52:23 GMT 2023
|
||
|
DSLD |
3129 (Number of products:660)
Created by
admin on Fri Dec 15 15:52:23 GMT 2023 , Edited by admin on Fri Dec 15 15:52:23 GMT 2023
|
||
|
LOINC |
25119-9
Created by
admin on Fri Dec 15 15:52:23 GMT 2023 , Edited by admin on Fri Dec 15 15:52:23 GMT 2023
|
||
|
LOINC |
13780-2
Created by
admin on Fri Dec 15 15:52:23 GMT 2023 , Edited by admin on Fri Dec 15 15:52:23 GMT 2023
|
||
|
LOINC |
29632-7
Created by
admin on Fri Dec 15 15:52:23 GMT 2023 , Edited by admin on Fri Dec 15 15:52:23 GMT 2023
|
||
|
NCI_THESAURUS |
C73539
Created by
admin on Fri Dec 15 15:52:23 GMT 2023 , Edited by admin on Fri Dec 15 15:52:23 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
10853
Created by
admin on Fri Dec 15 15:52:23 GMT 2023 , Edited by admin on Fri Dec 15 15:52:23 GMT 2023
|
PRIMARY | |||
|
DB11102
Created by
admin on Fri Dec 15 15:52:23 GMT 2023 , Edited by admin on Fri Dec 15 15:52:23 GMT 2023
|
PRIMARY | |||
|
68310
Created by
admin on Fri Dec 15 15:52:23 GMT 2023 , Edited by admin on Fri Dec 15 15:52:23 GMT 2023
|
PRIMARY | |||
|
DTXSID7046045
Created by
admin on Fri Dec 15 15:52:23 GMT 2023 , Edited by admin on Fri Dec 15 15:52:23 GMT 2023
|
PRIMARY | |||
|
C61853
Created by
admin on Fri Dec 15 15:52:23 GMT 2023 , Edited by admin on Fri Dec 15 15:52:23 GMT 2023
|
PRIMARY | |||
|
100000088304
Created by
admin on Fri Dec 15 15:52:23 GMT 2023 , Edited by admin on Fri Dec 15 15:52:23 GMT 2023
|
PRIMARY | |||
|
C025787
Created by
admin on Fri Dec 15 15:52:23 GMT 2023 , Edited by admin on Fri Dec 15 15:52:23 GMT 2023
|
PRIMARY | |||
|
N-Acetyl-L-tyrosine
Created by
admin on Fri Dec 15 15:52:23 GMT 2023 , Edited by admin on Fri Dec 15 15:52:23 GMT 2023
|
PRIMARY | |||
|
21563
Created by
admin on Fri Dec 15 15:52:23 GMT 2023 , Edited by admin on Fri Dec 15 15:52:23 GMT 2023
|
PRIMARY | |||
|
DA8G610ZO5
Created by
admin on Fri Dec 15 15:52:23 GMT 2023 , Edited by admin on Fri Dec 15 15:52:23 GMT 2023
|
PRIMARY | |||
|
208-671-3
Created by
admin on Fri Dec 15 15:52:23 GMT 2023 , Edited by admin on Fri Dec 15 15:52:23 GMT 2023
|
PRIMARY | |||
|
DA8G610ZO5
Created by
admin on Fri Dec 15 15:52:23 GMT 2023 , Edited by admin on Fri Dec 15 15:52:23 GMT 2023
|
PRIMARY | |||
|
SUB12166MIG
Created by
admin on Fri Dec 15 15:52:23 GMT 2023 , Edited by admin on Fri Dec 15 15:52:23 GMT 2023
|
PRIMARY | |||
|
4481
Created by
admin on Fri Dec 15 15:52:23 GMT 2023 , Edited by admin on Fri Dec 15 15:52:23 GMT 2023
|
PRIMARY | |||
|
1010106
Created by
admin on Fri Dec 15 15:52:23 GMT 2023 , Edited by admin on Fri Dec 15 15:52:23 GMT 2023
|
PRIMARY | |||
|
31005
Created by
admin on Fri Dec 15 15:52:23 GMT 2023 , Edited by admin on Fri Dec 15 15:52:23 GMT 2023
|
PRIMARY | RxNorm | ||
|
68561
Created by
admin on Fri Dec 15 15:52:23 GMT 2023 , Edited by admin on Fri Dec 15 15:52:23 GMT 2023
|
PRIMARY | |||
|
537-55-3
Created by
admin on Fri Dec 15 15:52:23 GMT 2023 , Edited by admin on Fri Dec 15 15:52:23 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |